This 12-minute presentation was given by Vamsee Pamula, Co-Founder & President of Baebies, in an online forum hosted by Medical Lab Observer (MLO). Watch the webinar to learn how digital microfluidics enables ultra-rapid thermocycling for PCR.
This presentation was given by Vamsee Pamula in a livestream on August 4, 2020 hosted by the PAS Summer Webinar Series – Neonatal Infectious Diseases I – regarding the performance of cCMV PCR assays in a disposable cartridge in a completely automated fashion to enable in-hospital screening.
This presentation was given by Dr. Michael Cotten in a livestream on July 24, 2020 hosted by the PAS Summer Webinar Series – Neonatal Hematology & Bilirubin Metabolism regarding the evaluation of a G6PD testing platform that uses 50 µL whole blood samples with turn-around time of 15 minutes.
Watch this recorded webinar with Jon Washburn, Staff Engineer at Baebies, as he discusses causes of positive newborn screening results for lysosomal storage disorders (LSDs) and ways to reduce false positives by optimizing first tier enzyme testing cutoffs and integrating second tier screening.
This presentation was given by Dr. Namasivayam Ambalavanan in a livestream on May 4, 2020 hosted by the Neonatal Kidney Collaborative. Due to the cancellation of PAS 2020 related to COVID-19, Baebies has developed this accessible presentation, derived from the accepted abstract.
Watch the lab workflow of Baebies SEEKER, an innovative FDA authorized and CE marked newborn screening platform for lysosomal storage disorders.
Simple droplet operations of dispensing from a reagent reservoir, droplet transport across electrodes, merging two droplets into a larger combined droplet, mixing the combined droplet, and splitting the droplet are accomplished by strategically applying voltages to electrodes on the cartridge printed circuit board.
Baebies SEEKER is an innovative FDA authorized newborn screening platform for lysosomal storage disorders. With SEEKER, time from punch to referral can be as little as one day! Earlier detection and referral can lead to earlier treatment and can dramatically improve the baby’s outcome.
Baebies SEEKER is an innovative FDA authorized newborn screening platform for lysosomal storage disorders. SEEKER is a product you can count on from day one, requiring no daily maintenance or upkeep!
Baebies SEEKER is an innovative FDA authorized newborn screening platform for lysosomal storage disorders. SEEKER’s ease of use can simplify the newborn screening process in your lab. If you can pipette, you can use SEEKER!
- Page 1 of 2